Kyung Oh Johanson

Title: Innovator Kyung Oh Johanson: Advancements in Antigen Binding Proteins

Introduction

Kyung Oh Johanson, a prominent inventor based in King of Prussia, Pennsylvania, has made significant contributions to the field of biochemistry and medical research. With a remarkable portfolio of 11 patents, Johanson's innovative work focuses on the development of antigen binding proteins and their applications in cancer treatment.

Latest Patents

Johanson's latest patents include groundbreaking work on antigen binding proteins, specifically antibodies that bind to HER3. This patent outlines the composition of these proteins, their encoding polynucleotides, and their utility in the treatment and prevention of various cancers, including breast, ovarian, prostate, bladder, pancreatic, gastric, melanoma, and others that overexpress HER3. Additionally, Johanson has patented a method for expressing protein GB1 domain fusion proteins in mammalian cells, leveraging the B1 domain of Protein G as an epitope tag for enhanced protein over-expression.

Career Highlights

Throughout his career, Johanson has been associated with renowned companies such as SmithKline Beecham Corporation and GlaxoSmithKline LLC. His work in these organizations has facilitated groundbreaking advancements in pharmaceutical development and medical research.

Collaborations

Kyung Oh Johanson has collaborated with esteemed colleagues, including Zdenka Ludmila Jonak and Alexander H. Taylor. These partnerships have fostered an environment of innovation and contributed to significant advancements in their fields.

Conclusion

Kyung Oh Johanson's contributions to the field of antigen binding proteins exemplify the impact of dedicated research and innovation. As he continues to explore new frontiers in biochemistry, his work remains a beacon of hope in the fight against cancer and demonstrates the transformative power of scientific inquiry.